Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: A report of 175 cases

Journal of Neurology Neurosurgery and Psychiatry

Volumn 64, Issue 6, 1998, Pages 751-757

  Jitpimolmard, Suthipun ^a   Tiamkao, Somsak ^a   Laopaiboon, Malinee ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Botulinum toxin type A; Dysport; Hemifacial spasm; Long term treatment

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; DRUG EFFICACY; FOLLOW UP; HEMIFACIAL SPASM; HUMAN; INJECTION SITE; LONG TERM CARE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PTOSIS; RATING SCALE; STATISTICAL ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031777721     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.64.6.751     Document Type: Article

References (28)

1. Digre K, Corbett JJ. Hemifacial spasm: differential diagnosis, mechanism, and treatment. Adv Neurol 1988;49:151-76.
2. Elston JS. Botulinum toxin treatments of hemifacial spasm. J Neurol Neurosurg Psychiatry 1986;49:827-9.
3. Baker FG, Jannetta PJ, Bissonette DJ, et al. Microvascular decompression for hemifacial spasm. J Neurosurg 1995;82: 201-10.
4. Piatt JK, Wilkins RH. Treatments of tic douloureux and hemifacial spasm by posterior fossa exploration: therapeutic implications of various neurovascular relationships. Neurosurgery 1984;14:462-71.
5. Loeser JP, Chen J. Hemifacial spasm: treatments by microsurgical facial nerve decompression. Neurosurgery 1983;12: 141-6.
6. Report of the Therapeutics and Technology Assessment Subcommittee on the American Academy of Neurology. Assessment: the clinical usefulness of botulinum toxin A in treating neurologic disorders. Neurology 1990;40:1332-6.
7. Simpson LL. Molecular pharmacology of botulinum toxin and tetanus toxin. Ann Rev Pharmacol Toxicol 1986;26:427-53.
8. Van den Bergh P, Francart J, Mourin S, et al. Five year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin. Muscle Nerve 1995;18:720-9.
9. Chong PN, Ong B, Chan R. Botulinum toxin in the treatment of facial dyskinesias. Ann Acad Med Singapore 1991;20:223-7.
10. Yu YL, Fong KY, Chang CM. Treatments of idiopathic hemifacial spasm with botulinum toxin. Acta Neurol Scand 1992;85:55-7.
11. Elston JS. The management of blepharospasm and hemifacial spasm. J Neurol 1992;239:5-8.
12. Kraft SP, Lang AE. Botulinum toxin injection in the treatments of blepharospasm, hemifacial spasm, and eyelid fasciculation. Can J Neurol Sci 1988;15:276-80.
13. Frueh BR, Musch DC. Treatment of facial spasms with botulinum toxin. Ophthalmology 1986;93:917-23.
14. Price J, O'Day J. Efficacy and side effects of botulinum toxin treatment for blepharospasm and hemifacial spasm. Aust N Z J Ophthalmol 1994;22:255-60.
15. Zeger SL, Liang K-Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
16. Shaari CM, Sanders I. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis. Muscle Nerve 1993;16:964-9.
17. Jankovic J. Pretarsal injection of botulinum toxin for blepharospasm and apraxia of eyelid opening. J Neurol Neurosurg Psychiatry 1996;60:704.
18. Aramideh M, Ongerboer de Visser BW, Brans JWM, et al. Pretarsal application of botulinum toxin for treatment of blepharospasm. J Neurol Neurosurg Psychiatry 1995;59: 309-11.
19. Carruthers J, Carruthers A, Bagaric D. Can ptosis incidence be reduced after lid injections of botulinum toxin A exotoxin for blepharospasm and hemifacial spasm? Can J Ophthalmol 1995;30:147.
20. Frueh BR, Felt DP, Wojno TH, et al. Treatment of blepharospasm with botulinum toxin. Arch Ophthalmol 1984;102: 1464-8.
21. Tsoy EA, Buckley EG, Dutton JJ. Treatment of blepharospasm with botulinum toxin. Am J Ophthalmol 1985;99: 176-9.
22. Poungvarin N, Viriyavejakul A. Two hundred and fifty patients with hemifacial spasm treated with botulinum toxin injection. J Med Assoc Thai 1992;75:199-203.
23. Poungvarin N, Devahastin V, Viriyavejakul A. Treatment of various movement disorders with borulinum A toxin injection: an experience of 900 patients. J Med Assoc Thai 1995;78:281-8.
24. Poungvarin N, Viriyavejakul A, Komoltri C. Placebo-controlled double-blind cross-over study of botulinum A toxin in hemifacial spasm. Parkinsonism and Related Disorders 1995;1:85-8.
25. Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 1990;53:633-9.
26. Dutton JJ, Buckley EG. Long term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology 1988;95:1529-34.
27. Taylor JDN, Kraft SP, Kazdan MS, et al. Treatment of blepharospasm and hemifacial spasm with botulinum A toxin : a Canadian multicenter study. Can J Ophthalmol 1991;26:133-8.
28. Flanders M, Chin D, Boghen D. Botulinum toxin: preferred treatment for hemifacial spasm. Eur Neurol 1993;33:316-9.